Publication | Closed Access

(+)-Syringaresinol-di-O-β-d-glucoside, a phenolic compound from Acanthopanax senticosus Harms, suppresses proinflammatory mediators in SW982 human synovial sarcoma cells by inhibiting activating protein-1 and/or nuclear factor-κB activities

InflammationMedicinal ChemistryAnti-inflammatoryChemoprevention StrategyMedicineImmunologyAcanthopanax Senticosus HarmsPathologyPharmacological AgentProinflammatory MediatorsPhenolic CompoundPharmacotherapyImmunotherapeuticsAnti-cancer AgentPharmacologyDrug Discovery